Bringing Zilmax back won’t be easy for Merck
By P.J. Huffstutter and Lisa Baertlein
U.S. pharmaceutical giant Merck & Co. faces significant challenges bringing its controversial feed additive Zilmax back to market in the United States and Canada, even after a vote of confidence from South Korea on Thursday.
Are you a newspaper subscriber but you don't have a Digital Access account yet? Activate your account.
You will need your subscription account number and phone number. Not sure if you have an account? Email us or call (605) 996-5514 and we can help you.